期刊文献+

子宫内膜异位症的药物治疗进展 被引量:9

下载PDF
导出
摘要 子宫内膜异位症是很普通的妇科疾病,虽然手术治疗是治疗内异症的首选方法,但手术难以清除所有的病灶,术后内异症复发在所难免,因此药物治疗仍具有重要的地位。本文就近年来子宫内膜异位症的药物治疗做一概述。
出处 《安徽医药》 CAS 2008年第5期388-390,共3页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献17

  • 1Winkel CA. Evaluation and management of women with endometriosis [ J ]. Obestet Gynecol,2003,102 : 397 - 408.
  • 2葛秦生.临床生殖内分泌学[M].北京:科学技术出版社,2001.637-642.
  • 3Meresman GF, Auge L, Baranao RL, et al. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis[ J ]. Fertil Steril,2002 : 1141 - 7.
  • 4Mahutte NG, Arici A. Medical management of endometriosis - associated pain[J].Obstet Gynecol Clin N Am,2003,30:133 -50.
  • 5Vercellimi P,Fedele L,Pietropaolo G,et al. Progestogens for endometriosis:forward to the past[J]. Hum Reprod Update,2003,9:387 -96.
  • 6Olive DL. Medical therapy of endometriosis [J]. Semi Reprod Med, 2003,21:211 - 22.
  • 7Aanicki TI. Treatment of the pelvic pain associated with endometriosis using danazol vaginal suppositories. Two year followup[ J]. Fertil Stertil,2002,77 : S52 - 3.
  • 8苏丽,岳瑛.子宫内膜异位症的药物治疗[J].现代生物医学进展,2007,7(2):318-320. 被引量:8
  • 9李明江,李继俊,赵兴波,张秋实,王春霞.米非司酮和利洛司酮对异位子宫内膜间质细胞VEGF和PDGF的表达和体外增殖的影响[J].山东大学学报(医学版),2004,42(3):317-321. 被引量:5
  • 10刘晓鸿.米非司酮在子宫内膜异位症中的研究及应用[J].安徽医药,2004,8(6):464-465. 被引量:2

二级参考文献37

  • 1陈桂红.子宫内膜异位症的发病机理和治疗进展[J].现代生物医学进展,2006,6(12):149-151. 被引量:9
  • 2Ryan IP, Schriock ED, Taylor RN. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro [J]. J Clin Endocrinol Metab, 1994 , 78: 642.
  • 3Kettel LM, Murphy AA, Morales A J, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486)[J]. Fertil Steril, 1996, 65:23.
  • 4Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis [J].Hum Reprod, 1998, 13:1686.
  • 5Khan KN, Masuzaki H, Fujishita A, et al. Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium[J]. Fertil Steril, 2003,79:173.
  • 6Classen-Linke I, Alfer J, Krusche CA, et al. Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture[J]. Steroids, 2000, 65:763.
  • 7Murphy AA, Zhou MH, Malkapuram S, et al. RU486-induced growth inhibition of human endometrial cells[J]. Fertil Steril, 2000, 74: 1014.
  • 8Kumar S, Ghellal A, Li G. Breast carcinoma: vascular density determineal using CD105 antibody correlates with tumor prognosis[J]. Cancer Res, 1999, 59:856.
  • 9Desai NN, Goldfarb JM. Growth factor/cytokine secretion by a permanent human endometrial cell line with embryotrophic properties [J]. J Assist Reprod Genet, 1996,13:546.
  • 10Singer CF, Marbaix E, Lemoine P,et al. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts[J]. Eur J Biochem, 1999,259:40.

共引文献101

同被引文献113

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部